WEKO3
-
RootNode
アイテム
TREATMENT OUTCOMES OF CHEMORADIOTHERAPY FOR PATIENTS WITH STAGE IVA THORACIC ESOPHAGEAL CANCER AT OUR CENTER
http://hdl.handle.net/10295/1991
http://hdl.handle.net/10295/19917be66ab2-05f3-497b-ba5e-aae64585b99b
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
aktiai39(19).pdf (732.6 kB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2012-10-21 | |||||||||||||||||||||||
| タイトル | ||||||||||||||||||||||||
| タイトル | TREATMENT OUTCOMES OF CHEMORADIOTHERAPY FOR PATIENTS WITH STAGE IVA THORACIC ESOPHAGEAL CANCER AT OUR CENTER | |||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||||
| 言語 | ||||||||||||||||||||||||
| 言語 | eng | |||||||||||||||||||||||
| 主題 | ||||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||||||||
| 主題 | esophageal cancer | |||||||||||||||||||||||
| 主題 | ||||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||||||||
| 主題 | chemoradiotherapy | |||||||||||||||||||||||
| 資源タイプ | ||||||||||||||||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||||||||||||||||
| 資源タイプ | journal article | |||||||||||||||||||||||
| アクセス権 | ||||||||||||||||||||||||
| アクセス権 | open access | |||||||||||||||||||||||
| アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||||||||||||||||||||
| 作成者 |
Anbai, Akira
× Anbai, Akira
× Koga, Makoto
× Motoyama, Satoru
× Sato, Yusuke
× Jin, Mario
× Matsuhashi, Tamotsu
× Shibata, Hiroyuki
× Ohtsuka, Kazunori
× Hashimoto, Manabu
|
|||||||||||||||||||||||
| 内容記述 | ||||||||||||||||||||||||
| 内容記述タイプ | Abstract | |||||||||||||||||||||||
| 内容記述 | We evaluated the treatment outcomes of chemoradiotherapy for patients with unresectable advanced thoracic esophageal cancer. In total, 103 patients (99 men and 4 women) with unresectable cancer (stage IVA) were treated with chemoradiotherapy between April 2003 and December 2009. They ranged in age from 48 to 89 years, with a median age of 68 years. Two courses of chemotherapy (cisplatin［CDDP］ 40 mg/m^2 on Days 1 and 8 plus 5-fluorouracil［5-FU］ 400 mg/m^2 on Days 1 through 5 and on Days 8 through 12) and radiotherapy at doses of 59.4 to 66 Gy were administered. The mean follow-up period was 15.3 months (range, 2-88 months). The median overall survival was 13.9 months. The 2-year survival rate was 33.1% and the 3-year survival rate 17.0%. Complete response (CR) was obtained in 18 patients (17.5%). Nine of the 18 patients with CR developed recurrence. Severe hematological toxicities occurred, but were tolerable. | |||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||||
| 出版タイプ | ||||||||||||||||||||||||
| 出版タイプ | VoR | |||||||||||||||||||||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||||||||||||||||||
| 書誌情報 |
ja : 秋田医学 巻 39, 号 1, p. 19-26, 発行日 2012-09-28 |
|||||||||||||||||||||||
| 収録物識別子 | ||||||||||||||||||||||||
| 収録物識別子タイプ | ISSN | |||||||||||||||||||||||
| 収録物識別子 | 03866106 | |||||||||||||||||||||||
| 収録物識別子 | ||||||||||||||||||||||||
| 収録物識別子タイプ | NCID | |||||||||||||||||||||||
| 収録物識別子 | AN00009294 | |||||||||||||||||||||||
| 出版者 | ||||||||||||||||||||||||
| 出版者 | 秋田医学会 | |||||||||||||||||||||||
| 言語 | ja | |||||||||||||||||||||||
